HOLX

AI Research

Blackstone + TPG acquisition at $76/share → $18.3B enterprise value; deal expected H1 2026

Hologic entered into a definitive agreement to be acquired by funds managed by Blackstone and TPG for $76 per share in cash plus a non-tradable CVR of up to $3 per share, valuing the company at up to $18.3B enterprise value. The deal represents a ~46% premium to Hologic's May 2025 closing price, with minority investments from ADIA and GIC, and is expected to close in H1 2026 pending regulatory approvals. Despite the pending acquisition, Q1 2026 revenue rose 2.5% to $1.05B, though analyst sentiment remains cautious on diagnostics.